Search
Searching Content indexed under Intellectual Property by Kristin Wall ordered by Published Date Descending.
Links to Result pages
 
1 2 3  
>>Next
 
Title
Country
Organisation
Author
Date
1
Government Releases Final Amendments To The PMPRB's Patented Medicines Regulations To Lower The Prices Of Patented Medicines
The Government is moving forward with changes to the PMPRB intended to lower the prices of patented medicines in Canada
Canada
15 Aug 2019
2
Federal Court Of Appeal Agrees That The PMPRB Incorrectly Applied The Patent-Pertaining Analysis
The Federal Court of Appeal has provided new guidance on the proper approach to the "patent pertaining" analysis used by the Patented Medicine Prices Review Board, including on the identification of the medicine ...
Canada
11 Jul 2019
3
CUSMA Implementation Bill Introduced
CUSMA provides more protections for biologic and innovative pharmaceuticals under Canadian law.
Canada
10 Jun 2019
4
Top Headlines Of 2018
Last year ushered in a number of changes to the Canadian pharmaceutical and life sciences sector.
Canada
18 Jan 2019
5
Ontario Superior Court Rejects Apotex Attempts To Revive The Promise Doctrine By Dismissing Motion For Leave To Amend, Awards Substantial Indemnity Costs
The Ontario Superior Court of Justice (ONSC) recently denied Apotex's attempt to repackage the now defunct "promise of the patent" doctrine (the Promise Doctrine).
Canada
22 Nov 2018
6
New Protections For Biologics And Other Pharmaceuticals Under The United States-Mexico-Canada Agreement (USMCA)
As we reported, Canada has joined a new trilateral trade deal called the United States-Mexico-Canada Agreement (USMCA).
Canada
16 Oct 2018
7
CETA Tracker: Update On CSPs
To date, a total of 14 CSPs have been issued and three have been refused.
Canada
1 Oct 2018
8
Health Canada Releases Updated Guidance On Amended PM(NOC) Regulations
•The scope and application of section 5 of Regulations, including providing clarification for the types of submissions that will be captured by the provision when a second person applies for an NOC.
Canada
15 Aug 2018
9
First Motion For Early Patent Dismissal Fails To Meet High Burden Under Newly-Amended PM(NOC) Regulations
On July 6, 2018, the Federal Court dismissed the first motion brought under section 6.08 of the newly-amended Patented Medicines (Notice of Compliance) Regulations (the Regulations).
Canada
1 Aug 2018
10
CETA Tracker: Update On CSPs
The protection given under a CSP is intended to "partly compensate for time spent in research and obtaining marketing authorization.
Canada
29 May 2018
11
Standing Committee On Health Releases Report And Recommendations On National Pharmacare
On April 18, 2018 the Standing Committee on Health tabled its report on national pharmacare entitled Pharmacare Now: Prescription Medicine Coverage for All Canadians.
Canada
25 May 2018
12
CETA Tracker: Update On Section 6 Actions Under The Patented Medicines (Notice Of Compliance) Regulations
As we reported, Canada implemented a single-track pharmaceutical patent litigation regime through amendments to the Patented Medicines (Notice of Compliance) Regulations (the Regulations) on September 21, 2017.
Canada
25 May 2018
13
Apotex Request To Re-Open Validity Of Esomeprazole Patent Denied
The Federal Court dismissed Apotex's motion to re-open the validity phase of the patent infringement action relating to esomeprazole (AstraZeneca's NEXIUM®).
Canada
25 May 2018
14
Pharma In Brief - CETA Tracker: Patent Term Restoration Is Coming Soon To Canada – What You Need To Know Now
With Canada moving closer towards implementing the Comprehensive Economic and Trade Agreement (CETA), major reforms to Canada's Patent Act are coming soon, including the availability of Certificates of Supplementary Protection (CSPs): ..
Canada
5 May 2017
15
Pharma In Brief - FCA Finds No Failure To Mitigate Apotex Damages Claim Against Health Canada For Delayed Apo-Trazodone NOC
The Federal Court of Appeal allowed Apotex's appeal, in part, from the Federal Court decision that found Apotex was entitled to damages for misfeasance of public office and negligence ...
Canada
24 Apr 2017
16
CETA Tracker: Significant Amendments to the Patent Act Affecting Pharmaceuticals Nearly in Force
Major reforms to Canada's Patent Act are coming as the Canadian Parliament moves one step closer to ratifying the Comprehensive Economic and Trade Agreement (CETA).
Canada
31 Mar 2017
17
Pharma In Brief - PMPRB Switches To Complaint-Based Process For Patented Generic Drug Price Review
In its February 2017 newsletter, the PMPRB announced its intention to move patented generic drug price reviews to a complaint-based process, similar to the provisions for over-the-counter drug products...
Canada
20 Feb 2017
18
Pharma In Brief - Federal Court Upholds The Constitutionality Of The Patent Act's Price Control Provisions And The PMPRB's Powers To Amend Excessive Pricing Allegations
Alexion Pharmaceuticals Inc. brought two judicial reviews in relation to the Patented Medicine Prices Review Board's excessive price proceeding over its drug SOLIRIS® (eculizumab).
Canada
13 Feb 2017
19
Pharma In Brief - Federal Court Upholds The Constitutionality Of The Patent Act's Price Control Provisions And The PMPRB's Powers To Amend Excessive Pricing Allegations
Alexion Pharmaceuticals Inc. brought two judicial reviews in relation to the Patented Medicine Prices Review Board's (the PMPRB or the Board) excessive price proceeding over its drug SOLIRIS® (eculizumab).
Canada
14 Jan 2017
20
Pharma In Brief - PMPRB Explores Application Of The "Patent Pertaining" Analysis To Formulations And Combination Drugs In Failure-To-File Application
These two combination patents, the panel held, were not intended or capable of being used to make an adapalene monotherapy on the basis that a simple reference to adapalene in the patents was insufficient to establish the necessary rational connection.
Canada
9 Jan 2017
Links to Result pages
 
1 2 3  
>>Next